ArticleFrontiers in endocrinology2026
Maternal high-fat diet exposure is associated with altered hypothalamic microglial development and reduced early postnatal TGFβ1 signaling in male offspring.
Article in Frontiers in endocrinology, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
3 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Background: The hypothalamus plays a central role in maintaining energy homeostasis by integrating peripheral metabolic signals. Maternal high-fat diet (HFD) exposure has been shown to disrupt hypothalamic development and increase offspring susceptibility to metabolic disorders. Microglia, as key regulators of neuroimmune interactions and synaptic remodeling, are increasingly recognized as critical mediators of metabolic programming. During early postnatal development, microglia undergo a transition toward a homeostatic phenotype characterized by markers such as TMEM119, a process that is critically dependent on canonical TGFβ1/SMAD3 signaling. However, whether maternal HFD exposure interferes with the acquisition of homeostatic-like microglial features during this sensitive developmental window remains unclear. Methods: We characterized the postnatal trajectory of hypothalamic microglia-associated developmental features using single-cell RNA sequencing and temporally resolved immunohistochemical analyses in male offspring of HFD-fed dams. Microglial abundance, morphology, and expression of homeostatic markers were assessed across developmental stages in the mediobasal hypothalamus (MBH). Canonical TGFβ1 signaling activity was evaluated by pSMAD3 immunoreactivity, and Parkin-associated signals were quantified within hypothalamic tissue and microglia-defined regions of interest. To assess whether restoration of local TGFβ1 signaling influences microglia-associated developmental features, neonatal MBH supplementation with recombinant TGFβ1 was performed. Results: Single-cell transcriptomic analysis revealed that hypothalamic microglia progressively acquired homeostatic-associated transcriptional features during early postnatal development, with increasing enrichment of homeostatic marker-associated signatures by the juvenile stage. Maternal HFD exposure attenuated the developmental increase of TMEM119 Conclusion: These findings support a developmental association between maternal HFD exposure, reduced early postnatal TGFβ1/SMAD3 signaling within the MBH, and altered acquisition of homeostatic-like microglial features in the hypothalamus. These developmental neuroimmune alterations may contribute to increased susceptibility to later metabolic dysfunction in male offspring.
Indexed as
Identifiers
What Socratic holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.